New vax “could prevent 90% of cervical cancer cases”

schoolkids school kids young girls teenager girl's health gardasl HPV vaccine
With strong new evidence published this week, the PBAC has recommended the 9-valent HPV vaccine replace the current quadrivalent one In response to a request from manufacturer Seqirus, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that Gardasil 9 be listed on the National Immunisation Program as a two-dose schedule for females and males, aged 12-13

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Sigma acquires MPS, announces half-year results
Next Knowledge gap